Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,020 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00510068 | Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors(RADIANT-3) | completed | Phase 3 | 410 | Novartis PharmaceuticalsINDUSTRY | 18 | Jul 1, 2015 | clinicaltrials |
| NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL(ALL-SCT-BFMi) | unknown | Phase 3 | 405 | St. Anna KinderkrebsforschungOTHER | 11 | Jun 26, 2015 |
| clinicaltrials |
| NCT01016795 | Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma(SCF980266) | terminated | Phase 2 | 32 | Aalborg University HospitalOTHER | 4 | Jun 25, 2015 | clinicaltrials |
| NCT01056510 | A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe) | completed | Phase 4 | 357 | Hoffmann-La RocheINDUSTRY | 8 | Jun 25, 2015 | clinicaltrials |
| NCT00954746 | Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859 | completed | — | 645 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 6 | Jun 16, 2015 | clinicaltrials |
| NCT02030717 | Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma(ASA) | completed | Phase 2 / Phase 3 | 120 | Umeå UniversityOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01323790 | Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation | completed | Phase 3 | 700 | AstraZenecaINDUSTRY | 8 | Jun 2, 2015 | clinicaltrials |
| NCT01418326 | Cancer Mortality Affected by the Choice of Anesthetic Drugs? | completed | — | 3,284 | EnlundOTHER | 1 | May 29, 2015 | clinicaltrials |
| NCT01510236 | Self-help Program Via Internet for Adolescents With Cancer(U-CARE:TeenCan) | withdrawn | Phase 2 | 0 | Uppsala UniversityOTHER | 1 | May 28, 2015 | clinicaltrials |
| NCT00796757 | A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). | completed | Phase 2 | 146 | Hoffmann-La RocheINDUSTRY | 12 | May 27, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01229813 | Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.(ACT2) | completed | Phase 3 | 233 | Lund University HospitalOTHER | 2 | Apr 13, 2015 | clinicaltrials |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)(OPTIMAL) | completed | Phase 3 | 169 | PfizerINDUSTRY | 18 | Mar 30, 2015 | clinicaltrials |
| NCT00254891 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 3 | 828 | PfizerINDUSTRY | 26 | Mar 30, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT00838357 | A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).(PREDICT) | completed | Phase 3 | 118 | Genzyme, a Sanofi CompanyINDUSTRY | 7 | Mar 24, 2015 | clinicaltrials |
| NCT00065325 | The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer(EFECT) | completed | Phase 3 | 694 | AstraZenecaINDUSTRY | 15 | Feb 24, 2015 | clinicaltrials |
| NCT00687570 | Bowel Preparation Before Rectal Cancer Surgery | completed | N/A | 32 | Karolinska InstitutetOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT01831245 | Right-sided Colon Tumor, Laparoscopic Versus Open Surgery, in an ERAS Protocol | completed | — | 125 | Karolinska InstitutetOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT00355355 | A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 3 | 208 | Light Sciences OncologyINDUSTRY | 11 | Jan 30, 2015 | clinicaltrials |
| NCT00660582 | FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor | completed | Phase 2 | 152 | Per PfeifferOTHER | 3 | Jan 21, 2015 | clinicaltrials |
| NCT01254279 | Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen | completed | Phase 3 | 984 | SanofiINDUSTRY | 29 | Jan 21, 2015 | clinicaltrials |
| NCT00863746 | A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).(MISSION) | completed | Phase 3 | 703 | BayerINDUSTRY | 34 | Jan 19, 2015 | clinicaltrials |
| NCT00415181 | Pharmacogenomics of Paclitaxel in Ovarian Cancer | completed | — | 93 | University of Southern DenmarkOTHER | 2 | Jan 13, 2015 | clinicaltrials |
| NCT01858116 | PET Study of Breast Cancer Patients Using [68Ga]ABY-025 | completed | Phase 1 / Phase 2 | 16 | Biomedical Radiation SciencesOTHER | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01373983 | Intrathecal Bolus Doses of Ziconotide(ZicBol) | completed | Phase 4 | 26 | University Hospital, LinkoepingOTHER | 1 | Dec 30, 2014 | clinicaltrials |
| NCT00598845 | Molecular Markers in Treatment in Endometrial Cancer(MoMaTEC) | unknown | — | 1,000 | University of BergenOTHER | 3 | Dec 23, 2014 | clinicaltrials |
| NCT00306150 | Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy | terminated | Phase 3 | 57 | BayerINDUSTRY | 7 | Dec 17, 2014 | clinicaltrials |
| NCT02016391 | Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours | completed | Phase 4 | 50 | Uppsala University HospitalOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01479946 | Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin | withdrawn | Phase 2 | 0 | Uppsala University HospitalOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01664663 | Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy(PLANET) | terminated | Phase 2 | 37 | Ass. Prof. Jan NymanNETWORK | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01502189 | Information to Parents of Children With Cancer. An Exploratory Study | completed | N/A | 8 | Umeå UniversityOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT00412061 | Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor(RADIANT-2) | completed | Phase 3 | 429 | Novartis PharmaceuticalsINDUSTRY | 15 | Nov 21, 2014 | clinicaltrials |
| NCT01296984 | Oncological and Functional Result of AbdominoPerineal Extra Levator Resection for Distal Rectal Cancer(APER) | completed | — | 1,319 | Sahlgrenska University HospitalOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01650805 | Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) | terminated | Phase 3 | 307 | Ariad PharmaceuticalsINDUSTRY | 24 | Nov 17, 2014 | clinicaltrials |
| NCT01595087 | A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC) | completed | Phase 1 / Phase 2 | 28 | DexTech Medical ABINDUSTRY | 1 | Nov 14, 2014 | clinicaltrials |
| NCT00764621 | Health Economic Evaluation of Primovist-enhanced Liver MRI | completed | Phase 4 | 360 | BayerINDUSTRY | 9 | Nov 4, 2014 | clinicaltrials |
| NCT00123487 | Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML | completed | Phase 3 | 638 | Bristol-Myers SquibbINDUSTRY | 32 | Nov 3, 2014 | clinicaltrials |
| NCT01574846 | Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer(Vantas) | completed | — | 142 | Orion Corporation, Orion PharmaINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00555919 | ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer | completed | Phase 2 | 68 | BayerINDUSTRY | 10 | Oct 10, 2014 | clinicaltrials |
| NCT01473563 | A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 6, 2014 | clinicaltrials |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | completed | Phase 3 | 2,067 | Hoffmann-La RocheINDUSTRY | 34 | Sep 30, 2014 | clinicaltrials |
| NCT01502982 | Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)(CRY-04) | completed | Phase 2 | 160 | Nordic Lymphoma GroupNETWORK | 4 | Sep 30, 2014 | clinicaltrials |
| NCT01609010 | A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma | completed | Phase 3 | 313 | Hoffmann-La RocheINDUSTRY | 3 | Sep 8, 2014 | clinicaltrials |
| NCT00576758 | GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma | completed | Phase 2 | 175 | Hoffmann-La RocheINDUSTRY | 17 | Aug 19, 2014 | clinicaltrials |
| NCT01214720 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | completed | Phase 3 | 607 | Hoffmann-La RocheINDUSTRY | 21 | Aug 13, 2014 | clinicaltrials |
| NCT02215577 | ALPPS Versus PVE/PL(LIGRO) | unknown | N/A | 100 | Regionalt Cancercentrum VästOTHER | 3 | Aug 13, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials